User profiles for Flavio A. Cadegiani
Flavio A CadegianiCorpometria Institute; Applied Biology Verified email at unifesp.br Cited by 1988 |
Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension?
FA Cadegiani - American Journal of Physiology …, 2020 - journals.physiology.org
Preliminary data on COVID-19 suggest hypertension to be correlated with worse outcomes (23.2%)
compared with that of other metabolic disorders. This observation has been …
compared with that of other metabolic disorders. This observation has been …
[PDF][PDF] 5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia
FA Cadegiani, S Herrera - 2021 - minerva-access.unimelb.edu.au
Dear Editor, We have previously reported that men with androgenetic alopecia (AGA) are
more likely to present with severe COVID-19 symptoms, potentially implicating androgen …
more likely to present with severe COVID-19 symptoms, potentially implicating androgen …
[HTML][HTML] Spironolactone: an anti-androgenic and anti-hypertensive drug that may provide protection against the novel coronavirus (SARS-CoV-2) induced acute …
FA Cadegiani, CG Wambier, A Goren - Frontiers in Medicine, 2020 - frontiersin.org
At the onset of the COVID-19 pandemic, mortality following infection of severe acute
respiratory coronavirus (SARS-CoV-2) was thought to be solely associated with aging and pre-…
respiratory coronavirus (SARS-CoV-2) was thought to be solely associated with aging and pre-…
[HTML][HTML] Proxalutamide reduces the rate of hospitalization for COVID-19 male outpatients: a randomized double-blinded placebo-controlled trial
J McCoy, A Goren, FA Cadegiani… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Antiandrogens have demonstrated a protective effect for COVOD-19 patients in observational
and interventional studies. The goal of this study was to determine if proxalutamide, an …
and interventional studies. The goal of this study was to determine if proxalutamide, an …
[PDF][PDF] Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men
…, PM Ramos, FA Cadegiani… - Journal of the …, 2021 - escholarship.org
Peer reviewed eScholarship. org Powered by the California Digital Library University of
California was positive in eight cases, borderline in two, and negative in three, including the …
California was positive in eight cases, borderline in two, and negative in three, including the …
[HTML][HTML] Remission of severe myasthenia gravis after massive-dose vitamin D treatment
FA Cadegiani - The American journal of case reports, 2016 - ncbi.nlm.nih.gov
Objective: Unusual or unexpected effect of treatment Background: Vitamin D has been
shown to be related to autoimmune diseases, such as multiple sclerosis and psoriasis. …
shown to be related to autoimmune diseases, such as multiple sclerosis and psoriasis. …
[HTML][HTML] Androgen receptor genetic variant predicts COVID‐19 disease severity: a prospective longitudinal study of hospitalized COVID‐19 male patients
…, RM Iwasiow, MA Tayeb, FA Cadegiani… - Journal of the …, 2021 - ncbi.nlm.nih.gov
5 Montopoli M, Zumerle S, Vettor R et al. Androgen-deprivation therapies for prostate cancer
and risk of infection by SARS-CoV-2: a populationbased study (N= 4532). Ann Oncol 2020; …
and risk of infection by SARS-CoV-2: a populationbased study (N= 4532). Ann Oncol 2020; …
[HTML][HTML] Hormonal aspects of overtraining syndrome: a systematic review
FA Cadegiani, CE Kater - BMC Sports Science, Medicine and …, 2017 - Springer
Background Overtraining syndrome (OTS), functional (FOR) and non-functional overreaching
(NFOR) are conditions diagnosed in athletes with decreased performance and fatigue, …
(NFOR) are conditions diagnosed in athletes with decreased performance and fatigue, …
[PDF][PDF] Early antiandrogen therapy with dutasteride reduces viral shedding, inflammatory responses, and Time-to-Remission in males with COVID-19: a randomized …
FA Cadegiani, J McCoy, CG Wambier, A Goren - Cureus, 2021 - cureus.com
Background and objective Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
cell entry and subsequent infectivity are mediated by androgens and the androgen …
cell entry and subsequent infectivity are mediated by androgens and the androgen …
[PDF][PDF] Proxalutamide significantly accelerates viral clearance and reduces time to clinical remission in patients with mild to moderate COVID-19: results from a …
Background The entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
into type II pneumocytes is dependent on a modification of viral spike proteins by …
into type II pneumocytes is dependent on a modification of viral spike proteins by …